Embryonic dysmorphogenesis has been blocked by antioxidant treatment in vivo and in vitro, suggesting that embryonic excess of reactive oxygen species (ROS) has a role in the teratogenic process of diabetic pregnancy. We report that the basal levels of ROS in dispersed rat embryonic cells in vitro, as determined by fluorescence of dichlorofluorescein (DCF), were not different in cells from control and diabetic pregnancy at day 10 or 12. β-Hydroxybutyrate (β-HB) and succinic acid monomethyl ester both augmented DCF fluorescence in cells from day 12 embryos of normal and diabetic rats but not from day 10 embryos. Cells of day 10 and day 12 embryos from normal and diabetic rats responded to increasing glucose concentrations with a dosage-dependent alleviation of DCF fluorescence. Day 10 embryonic cells exhibited high glucose utilization rates and high pentose phosphate shunt rates, but low mitochondrial oxidation rates. Moreover, in vitro culture of embryos between gestational days 9 and 10 in the presence of 20% oxygen induced an increased and glucose-sensitive oxidation of glucose compared with embryos not cultured in vitro. At gestation day 12, however, pentose phosphate shunt rates showed a decrease, whereas the mitochondrial P-HB oxidation rates were increased compared with those at gestation day 10. This was paralleled by a lower expression of glucose 6-phosphate dehydrogenase- and phosphofructokinase-mRNA levels at day 12 than at day 10. On the other hand, H-ferritin mRNA expression at day 12 was high compared with day 10. None of the mRNA species investigated were affected by the diabetic state of the mother. It was concluded that β-HB-induced stimulation of mitochondrial oxidative events may lead to the generation of ROS at gestational day 12, but probably not at day 10, when only a minute amount of mitochondrial activity occurs. Thus our results do not support the notion of diabetes-induced mitochondrial oxidative stress before the development of a placental supply of oxygen.
Skip Nav Destination
Article navigation
Pathophysiology|
February 01 1998
β-Hydroxybutyrate Increases Reactive Oxygen Species in Late but Not in Early Postimplantation Embryonic Cells In Vitro
Henrik Forsberg;
Henrik Forsberg
Department of Medical Cell Biology, Uppsala University
Uppsala
Search for other works by this author on:
Ulf J Eriksson;
Ulf J Eriksson
Department of Medical Cell Biology, Uppsala University
Uppsala
Search for other works by this author on:
Öjar Melefors;
Öjar Melefors
Department of Cell and Molecular Biology, Karolinska Institute
Stockholm, Sweden
Search for other works by this author on:
Nils Welsh
Nils Welsh
Department of Medical Cell Biology, Uppsala University
Uppsala
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Nils Welsh, Department of Medical Cell Biology, Biomedical Center, P.O. Box 571, S-751 23 Uppsala, Sweden.
Diabetes 1998;47(2):255–262
Article history
Received:
November 25 1996
Revision Received:
October 21 1997
Accepted:
October 21 1997
PubMed:
9519722
Citation
Henrik Forsberg, Ulf J Eriksson, Öjar Melefors, Nils Welsh; β-Hydroxybutyrate Increases Reactive Oxygen Species in Late but Not in Early Postimplantation Embryonic Cells In Vitro. Diabetes 1 February 1998; 47 (2): 255–262. https://doi.org/10.2337/diab.47.2.255
Download citation file:
49
Views